文献速递儿科与产科急症消化、代谢与肾脏急症

产后母亲阿片类药物治疗与婴儿不良结局风险:基于人群的队列研究

Maternal opioid treatment after delivery and risk of adverse infant outcomes: population based cohort study.
PubMed 文献 · BMJ · 2023-03-15
一句话结论基于人群队列显示,产后7天内开具阿片类处方与婴儿30天内再入院无关联(HR 0.98,95%CI 0.93–1.03),急诊就诊略多(HR 1.04)。

该研究在加拿大安大略省纳入2012年9月1日至2020年3月31日分娩后7天内活着出院的865 691对母婴,将出院后7天内填写阿片类处方的母亲与未填写者进行倾向评分匹配。主要终点为母亲填写阿片类处方(索引日期)后30天内婴儿因任何原因再入院。结果显示匹配后两组各85 675名母亲,婴儿再入院率均为3.5%(阿片组2962例 vs 非阿片组3038例),HR 0.98(95%CI 0.93–1.03);急诊就诊略多(HR 1.04,95%CI 1.01–1.08),其他婴儿不良结局无差异,无婴儿死亡。结论提示产后母亲阿片类处方与婴儿不良结局(包括死亡)无关。

要点

  • 产后7天内填写阿片类处方的母亲,其婴儿30天内因任何原因再入院的风险与未处方者无显著差异(HR 0.98,95%CI 0.93–1.03)。
  • 阿片组婴儿30天内急诊就诊略多于非阿片组(HR 1.04,95%CI 1.01–1.08)。
  • 婴儿全因损伤住院、新生儿重症监护病房入住、复苏或辅助通气入住及全因死亡等其他不良结局均无差异,且无婴儿死亡。
  • 匹配后两组婴儿30天内再入院率均为3.5%(阿片组2962例 vs 非阿片组3038例)。
  • 该研究为基于人群的队列研究,采用倾向评分匹配,结果提示产后阿片类处方与婴儿不良结局无关。

适用人群与场景

  • 2012年9月1日至2020年3月31日分娩后7天内活着出院的母婴对,共865 691对,来自加拿大安大略省。
  • 出院后7天内填写阿片类处方的母亲(85 852名中85 675名,99.8%)与未填写处方的母亲进行倾向评分匹配,各85 675名。

研究设计与关键结果

  • 研究设计:基于人群的队列研究,在加拿大安大略省纳入865 691对母婴,采用倾向评分匹配比较产后7天内填写阿片类处方与未填写处方的母亲。
  • 主要终点:婴儿在母亲填写阿片类处方(索引日期)后30天内因任何原因再入院;阿片组2962例(3.5%)vs 非阿片组3038例(3.5%),HR 0.98(95%CI 0.93–1.03)。
  • 次要终点:婴儿急诊就诊在后续30天内略多(HR 1.04,95%CI 1.01–1.08);全因损伤住院、新生儿重症监护病房入住、复苏或辅助通气入住及全因死亡均无差异,无婴儿死亡。

证据类型、等级与局限

  • 证据类型:基于人群的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该研究结果提示产后母亲阿片类处方与婴儿不良结局(包括死亡)无关,急诊就诊略多但无其他差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To examine whether maternal opioid treatment after delivery is associated with an increased risk of adverse infant outcomes.

DESIGN: Population based cohort study.

SETTING: Ontario, Canada.

PARTICIPANTS: 865 691 mother-infant pairs discharged from hospital alive within seven days of delivery from 1 September 2012 to 31 March 2020. Each mother who filled an opioid prescription within seven days of discharge was propensity score matched to a mother who did not.

MAIN OUTCOME MEASURES: The primary outcome was hospital readmission of infants for any reason within 30 days of their mother filling an opioid prescription (index date). Infant related secondary outcomes were any emergency department visit, hospital admission for all cause injury, admission to a neonatal intensive care unit, admission with resuscitation or assisted ventilation, and all cause death.

RESULTS: 85 675 mothers (99.8% of the 85 852 mothers prescribed an opioid) who filled an opioid prescription within seven days of discharge after delivery were propensity score matched to 85 675 mothers who did not. Of the infants admitted to hospital within 30 days, 2962 (3.5%) were born to mothers who filled an opioid prescription compared with 3038 (3.5%) born to mothers who did not. Infants of mothers who were prescribed an opioid were no more likely to be admitted to hospital for any reason than infants of mothers who were not prescribed an opioid (hazard ratio 0.98, 95% confidence interval 0.93 to 1.03) and marginally more likely to be taken to an emergency department in the subsequent 30 days (1.04, 1.01 to 1.08), but no differences were found for any other adverse infant outcomes and there were no infant deaths.

CONCLUSIONS: Findings from this study suggest no association between maternal opioid prescription after delivery and adverse infant outcomes, including death.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Zipursky JS, Gomes T, Everett K, et al. Maternal opioid treatment after delivery and risk of adverse infant outcomes: population based cohort study. BMJ. 2023. PMID: 36921977. doi:10.1136/bmj-2022-074005

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。